Recent studies highlighted that more cancer-specific molecular targets are also affected by metformin with high specificity, including the inhibition of the intracellular chloride channel 1 (CLIC1) activity20,21 and the dysregulation of proliferation-related miRNAs22. Here, CLIC1 is linked to cancer.